Sporadic Myotonic Dystrophy Type 2 in a Japanese Patient.


Journal

Internal medicine (Tokyo, Japan)
ISSN: 1349-7235
Titre abrégé: Intern Med
Pays: Japan
ID NLM: 9204241

Informations de publication

Date de publication:
15 Oct 2023
Historique:
medline: 15 11 2023
pubmed: 16 2 2023
entrez: 15 2 2023
Statut: ppublish

Résumé

We herein report a Japanese patient with myotonic dystrophy type 2 (DM2), which is rare in Japan. A 64-year-oldman had proximal muscle weakness and grip myotonia. Electromyography showed myotonic discharges, but dystrophia-myotonica protein kinase (DMPK) was negative for CTG repeats. A muscle biopsy revealed increased central nuclei, pyknotic nuclear clumps and muscle fiber atrophy, mainly in type 2 fibers, raising the possibility of DM2. The diagnosis was genetically confirmed by the abnormal CCTG repeat size in cellular nucleic acid-binding protein (CNBP) on repeat-primed polymerase chain reaction, which was estimated to be around 4,500 repeats by Southern blotting.

Identifiants

pubmed: 36792202
doi: 10.2169/internalmedicine.0425-22
pmc: PMC10641181
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3027-3031

Références

Neurology. 2003 Feb 25;60(4):657-64
pubmed: 12601109
Front Neurol. 2018 Jun 19;9:463
pubmed: 29973908
Neurol Sci. 2017 Apr;38(4):535-546
pubmed: 28078562
Muscle Nerve. 2004 Feb;29(2):275-81
pubmed: 14755494
J Hum Genet. 2012 Mar;57(3):219-20
pubmed: 22258159
Lancet Neurol. 2012 Oct;11(10):891-905
pubmed: 22995693
Neurology. 2017 Sep 26;89(13):1348-1354
pubmed: 28855409
Genes (Basel). 2022 Feb 17;13(2):
pubmed: 35205411
J Neurol. 2013 Oct;260(10):2497-504
pubmed: 23807151
Science. 2001 Aug 3;293(5531):864-7
pubmed: 11486088
J Neuromuscul Dis. 2015 Jul 22;2(s2):S59-S71
pubmed: 27858759
Neuroepidemiology. 2016;46(3):191-7
pubmed: 26882032
Eur J Hum Genet. 2011 Jul;19(7):776-82
pubmed: 21364698
Neurology. 2003 Jun 10;60(11):1854-7
pubmed: 12796551
Science. 1992 Mar 6;255(5049):1253-5
pubmed: 1546325
Neurogenetics. 2008 Feb;9(1):61-3
pubmed: 18057971
J Hum Genet. 2014 Mar;59(3):129-33
pubmed: 24430576

Auteurs

Koichi Miyashita (K)

Department of Neurology, Mie University Graduate School of Medicine, Japan.

Yuichiro Ii (Y)

Department of Neurology, Mie University Graduate School of Medicine, Japan.

Hirofumi Matsuyama (H)

Department of Neurology, Mie University Graduate School of Medicine, Japan.

Atsushi Niwa (A)

Department of Neurology, National Mie Hospital, Japan.

Yosuke Kawana (Y)

Department of Neurology, Saiseikai Matsusaka General Hospital, Japan.

Soshi Shibata (S)

Department of Neurology, Suzuka Chuo General Hospital, Japan.

Narihiro Minami (N)

Department of Genome Medicine Development, Medical Genome Center, National Center of Neurology and Psychiatry, Japan.
Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Japan.

Ichizo Nishino (I)

Department of Genome Medicine Development, Medical Genome Center, National Center of Neurology and Psychiatry, Japan.
Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Japan.

Hidekazu Tomimoto (H)

Department of Neurology, Mie University Graduate School of Medicine, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH